Aging Biotech Focus Apollo Health Ventures concentrates on aging and age-related diseases, including neurodegenerative programs, which signals demand for specialized R&D tools, data analytics, biomarker platforms, and collaborative development services to accelerate portfolio programs.

Co-Founder Strategy The firm actively co-founds and invests in early-stage companies, creating opportunities for joint ventures and co-development deals with portfolio firms; consider offerings centered on shared IP creation, strategic partnerships, and staged funding support.

Transatlantic Growth Based in Berlin with a transatlantic reach, Apollo can help portfolio companies scale in the US and EU, providing market-entry support, regulatory guidance, and access to a broader investor network for cross-border financing rounds.

Active Portfolio Recent investments in Cognito Therapeutics, Refoxy, and Booster demonstrate appetite for transformative biotech assets at early to growth-stage rounds; align with these portfolio-backed ventures through CRO, clinical development, and manufacturing partnerships.

Ecosystem & Partners A history of ecosystem-building through Focal Biosciences, Molecule, VitaDAO and other collaborations indicates sales opportunities around collaboration platforms, IP monetization, and data-enabled tools that support longevity R&D and biotech innovation.